Five GSBS students were inducted into Sigma Xi, the Scientific
Research Society this spring. These students were recognized
by graduate faculty for their outstanding research efforts
and nominated for induction by the Graduate Council.
 |
Joel Ellis
Ellis received his master’s degree at
the health science center and continued
into the doctoral program in biomedical
sciences. His research is in the
field of cardiac molecular biology and
genetic training, specifically addressing
research problems concerning nuclear
signal transduction
cascades in the regulation
of Class II
repression mechanisms
in the adult
rat heart. |
 |
Eric Gonzales
Gonzales is a
doctoral candidate
in pharmacology and neuroscience.
Gonzales’ research focuses on
understanding ion channels. He is
currently the president
of the Graduate
Student Association.
He has
served in the past
as both president
and vice- president
of the Society for
the Advancement
of Latino Scholars
in Academia and as
treasurer of the
Black Graduate Student Association. |
 |
Jae Kyung Lee
Lee is a doctoral candidate in
microbiology and immunology. Her
research focuses on understanding the
molecular mechanisms by which
immune cells recognize and kill cancer
cells, particularly the characterization
of the novel receptor CS1 in human
NK cells and Beta cells. 2003. Lee was also recently
selected to receive a Sigma Xi Grant-in-
Aid of Research award. |
 |
Anson Pierce
Pierce is a doctoral
candidate in
biochemistry and
molecular biology.
His research centers
on the characterization
of a new form
of the antioxidant
enzyme extracellular
superoxide dismutase
(ecSOD), which was first discovered in his lab in a
mouse model of atherosclerosis. He has
been a member of the institutional
animal care and use committee and is
currently a fellow for "Schools’ Opportunity
for Resources in Education". |
 |
Swapnil Vaidya
Vaidya is a doctoral candidate in
microbiology and immunology. His
research is in the field of cancer
immunology, with an emphasis on
how natural killer cells recognize cancer
cells and kill them. Specifically, he
studies the function and regulation of
an NK cell receptor called 2B4. The
ultimate goal of the research is to
design novel immune-based therapeutic
approaches to
cancer. |
